Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Industry

11 Nov 2021

First legal Psilocybin Mushroom group therapy treatment for nine end-of life-patients

My Community Journeys announced that they recently hosted the first legal group therapy session with psilocybin mushrooms ever in North America....

By Microdose

Industry

9 Nov 2021

Wonderland Day One: A huge success

We’ve been working on it for what seems like forever — and day one of Wonderland was a huge success....

By Microdose

Industry

8 Nov 2021

IMIO Partners With QuantaliX To Map Brain Network Response To Psychedelic Therapy

Press Release IMIO Partners With QuantaliX To Map Brain Network Response To Psychedelic Therapy The collaboration will apply QuantalX’s breakthrough device Delphi·MD™ technology to develop a comprehensive database relating to...

By Microdose

Events

8 Nov 2021

Microdose Announces Wonderland Miami’s Lineup of Sponsors

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Events

7 Nov 2021

Microdose Announces ClearMind Medicine as Wonderland Silver Sponsor

It’s an honor for Microdose to announce ClearMind Medicine as a Silver Sponsor of Wonderland: Miami 2021....

By Microdose

Events

6 Nov 2021

Microdose Announces Wonderland Miami’s Lineup of Sponsors

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Events

5 Nov 2021

Microdose Announces Irwin Naturals Emergence as Wonderland Gold Sponsor

It’s an honor for Microdose to announce Irwin Naturals Emergence as a Gold Sponsor of Wonderland: Miami 2021...

By Microdose

Events

5 Nov 2021

Microdose Announces Alvarius Pharmaceuticals as Wonderland Platinum Sponsor

It’s an honor for Microdose to announce Alvarius Pharmaceuticals as a Platinum Sponsor of Wonderland: Miami 2021...

By Microdose

Events

4 Nov 2021

Microdose Announces Cannabrand as Wonderland Private Room Sponsor

It’s an honor for Microdose to announce Cannabrand as Private Room Sponsor of Wonderland: Miami 2021....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.